Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study

Peer Review reports

Original Submission
24 May 2023	Submitted	Original manuscript
9 Jul 2023	Reviewed	Reviewer Report - Mojtaba Dorri
17 Jul 2023	Reviewed	Reviewer Report - carol osuji
26 Jul 2023	Author responded	Author comments - Kathrine Jakobsen
Resubmission - Version 2
26 Jul 2023	Submitted	Manuscript version 2
30 Jul 2023	Reviewed	Reviewer Report - Mojtaba Dorri
4 Aug 2023	Reviewed	Reviewer Report - carol osuji
11 Aug 2023	Author responded	Author comments - Kathrine Jakobsen
Resubmission - Version 3
11 Aug 2023	Submitted	Manuscript version 3
Publishing
17 Aug 2023	Editorially accepted
1 Sep 2023	Article published	10.1186/s13063-023-07594-5

Back to article page